UBS Group’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
2017
Q4
$1K Sell
2017
Q3
$7K Buy
2017
Q2
$3K Sell
2017
Q1
$53K Buy
2016
Q4
$1K Sell
2016
Q3
$71K Buy
2016
Q2
Sell
2016
Q1
$10K Buy
2015
Q3
Sell
2015
Q2
$62K Buy
2015
Q1
$1K Sell
2014
Q4
$33K Buy